Shares in gastrointestinal biopharma Synergy Pharmaceuticals Inc (NASDAQ:SGYP) are plunging by 30% this week, following the announcement of an equity offering to raise money. …
Innovative healthcare stock Synergy Pharmaceuticals Inc (NASDAQ:SGYP) has massive upside potential according to financial services firm BTIG, as it takes rare bearish stance …
Two healthcare companies with recently approved and much-hyped products- but which one makes a compelling investing opportunity right now? Synergy Pharmaceuticals Inc (NASDAQ:SGYP) specializes …
Synergy Pharmaceuticals (NASDAQ:SGYP) stock may be getting some heat in the market today after releasing third quarter results yesterday, yet one bullish voice …
Canaccord forecasts DTC marketing could be big for SGYP’s Trulance next year, in footsteps of rival Linzess.
By Bret Jensen Small biotech stocks especially ‘Tier 3‘ concerns like Omeros and Flexion Therapeutics have been taking it on the shin for most …
H.C.
This market-beating fund manager is slashing ACRX and SGYP, but upping ATRS.
Derek Archila thinking twice before ready to bet on Teva’s turnaround, but Synergy could bring some upside.
